Sengul Aydin Yoldemir1, Isil Kibar Akilli2, Muge Bilge1, Esra Canbolat Unlu3, Sebnem Izmir Guner4, Ekrem Guner5, Kadriye Kart Yasar3
1Department of Internal Medicine, University of Health Sciences, Cemil Tascioglu City Hospital, Istanbul, Turkey
2Department of Pulmonary Medicine, Sisli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey
3Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
4Department of Hematology and Bone Marrow Transplantation Unit, Gelisim University, Memorial Sisli Hospital, Istanbul, Turkey
5Department of Urology, University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
One of the reasons for the high mortality in COVID-19 patients is the increased risk of disseminated intravascular coagulation (DIC) and venous
thromboembolism. For this reason, the use of anticoagulant treatments has become widespread. One of the rare complications of anticoagulant therapy
is retroperitoneal hemorrhage. These hemorrhagies require immediate intervention. Retroperitoneal hemorrhage should be kept in mind among the
many complications that develop in the patient who was followed up during the pandemic period. For this purpose, we present 2 cases who developed
spontaneous retroperitoneal bleeding while clinically recovering under COVID-19 treatment.
Keywords : COVID-19, koronavirüs, retroperitoneal kanama, retroperitoneal hematom, retroperiton
